novavax covid vaccine

Order byBest matchMost fresh

FDA approves Novavax's Covid-19 vaccine

Top News

Overview

Impacts

Healthy Returns: Novavax scores narrower Covid vaccine approval after delay

Novavax can finally breathe a sigh of relief – at least a small one. The Food and Drug Administration approved the company's Covid-19 vaccine after more than a month of delay b

· 1d · on MSN

Clinical Advisor · 12h

FDA Approves Novavax’s COVID-19 Vaccine Nuvaxovid

· 4d · on MSN

After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk

WA vaccine scientists push back against FDA changes around COVID shots

Seattle vaccine experts were surprised and confused by the country’s apparent new direction around updated COVID-19 shots, which top officials at the Food and Drug Administration revealed Tuesday and ...

· 15h

· 1d

FDA tightens requirements for COVID vaccine, adding trials for healthy adults

· 1d

F.D.A. Poised to Restrict Access to Covid Vaccines

FDA plans to limit COVID vaccine to only high-risk people. Who would still be eligible?

Public trust in vaccination has declined, potentially impacting other vital immunization programs.

· 12h

· 1d

New FDA rule could delay Covid vaccine rollout for healthy adults and kids

· 1d

FDA sets new COVID booster guidelines for healthy adults under 65

13hon MSN

Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at higher risk of severe disease, but will require vaccine makers to conduct major new clinical trials before approving them for wider use.

14hon MSN

FDA’s new approach raises questions about fall COVID vaccine availability

Health experts say there are legitimate questions about how much everyone still benefits from yearly COVID vaccination or whether they should be recommended only for people at increased risk.

New Trump vaccine policy limits access to COVID shots

The Trump administration said Tuesday it will limit approval for seasonal COVID-19 shots to seniors and others at high risk pending more data on everyone else — raising questions

Novavax (NasdaqGS:NVAX) Reports Q1 2025 Financial Turnaround

Novavax (NasdaqGS:NVAX) recently reported a significant financial turnaround for Q1 2025, demonstrating substantial revenue growth and net income improvements. The amending of its collaboration agreement with Takeda offers increased flexibility in vaccine development,

2don MSN

RFK Jr. pledged not to upend US vaccine system, but big changes are underway

WASHINGTON — Robert F. Kennedy Jr. clinched the political support needed to become the nation’s top health official by pledging to work within the decades-old federal system for approval and use of vaccines. Yet his regulators are promising big changes that cloud the outlook for what shots might even be available.